Dialectical Behavioral Therapy Skills Training for Lung Cancer

Duke Cancer Institute, Durham, NC
Lung CancerDialectical Behavioral Therapy Skills Training - Behavioral
Eligibility
18+
All Sexes

Study Summary

This trial is testing whether an adapted form of dialectical behavioral therapy, which teaches patients skills to cope with emotional and physical symptoms, can help reduce psychological distress in metastatic lung cancer patients.

Eligible Conditions
  • Lung Cancer

Treatment Effectiveness

Study Objectives

5 Primary · 6 Secondary · Reporting Duration: Baseline, post-intervention, one month post-intervention (approximately week 0, week 18, week 12)

Week 18
Change in emotion regulation
Week 12
Behavior Therapy
Change in dyspnea
Change in fatigue
Change in pain
Change in psychological distress
Change in tolerance of uncertainty
Post-intervention (approximately 8 weeks)
Acceptability as measured by client satisfaction ratings
Feasibility as measured by study accrual
Feasibility as measured by study adherence
Feasibility as measured by study attrition

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

LiveWell: A Dialectical Behavioral Therapy Skills Training Protocol
1 of 2
Dialectical Behavioral Therapy Skills Training
1 of 2

Experimental Treatment

70 Total Participants · 2 Treatment Groups

Primary Treatment: Dialectical Behavioral Therapy Skills Training · No Placebo Group · N/A

LiveWell: A Dialectical Behavioral Therapy Skills Training Protocol
Behavioral
Experimental Group · 1 Intervention: Dialectical Behavioral Therapy Skills Training · Intervention Types: Behavioral
Dialectical Behavioral Therapy Skills Training
Behavioral
Experimental Group · 1 Intervention: Dialectical Behavioral Therapy Skills Training · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post-intervention, one month post-intervention (approximately week 0, week 18, week 12)

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,239 Previous Clinical Trials
3,040,665 Total Patients Enrolled
Tamara Somers, PhDPrincipal InvestigatorDuke University

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to communicate in and understand English.
You have experienced a high level of distress in the past week, as shown by a score of 4 or higher on a distress scale that measures your emotional well-being.
You understand the details of the study and agree to participate.

Frequently Asked Questions

How many participants have been recruited for this trial thus far?

"Affirmative, the clinicaltrials.gov data confirms that this trial is still welcoming applicants and was initially posted on May 18th 2022. This study has a need for 70 patients from 1 sites, with its information recently updated on June 14th 2022." - Anonymous Online Contributor

Unverified Answer

Are there still available openings for participants in this experiment?

"Correct. According to clinicaltrials.gov, recruitment is still ongoing for this trial which was initially posted on May 18th 2022 and latest updated June 14th 2022; 70 individuals are required from one location." - Anonymous Online Contributor

Unverified Answer

What outcome is this clinical experiment aiming to demonstrate?

"The goal of this investigation, which will be analysed over a 12 week period post-intervention is to assess its feasibility. Secondary objectives include an evaluation of emotional regulation via the Difficulties in Emotion Regulation Scale (DERS-18), fatigue using the Fatigue Symptom Inventory (FSI) and breathlessness with the Modified Medical Research Council Dyspnea Scale (MMRCDS)." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.